Terms: = Ovarian cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1 AND Treatment
35 results:
1. Modulatory effect of pomegranate peel extract on key regulators of ovarian cellular processes
Kolesarova A; Baldovska S; Kohut L; Vasicek J; Ivanisova E; Arvay J; Duracka M; Roychoudhury S
Front Endocrinol (Lausanne); 2023; 14():1277155. PubMed ID: 38027211
[TBL] [Abstract] [Full Text] [Related]
2. A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant cancers with B7-H4 Expression.
Gitto SB; Whicker M; Davies G; Kumar S; Kinneer K; Xu H; Lewis A; Mamidi S; Medvedev S; Kim H; Anderton J; Tang EJ; Ferman B; Coats S; Wilkinson RW; Brown E; Powell DJ; Simpkins F
Clin Cancer Res; 2024 Apr; 30(8):1567-1581. PubMed ID: 37882675
[TBL] [Abstract] [Full Text] [Related]
3. Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the treatment of cancer.
Toader D; Fessler SP; Collins SD; Conlon PR; Bollu R; Catcott KC; Chin CN; Dirksen A; Du B; Duvall JR; Higgins S; Kozytska MV; Bellovoda K; Faircloth C; Lee D; Li F; Qin L; Routhier C; Shaw P; Stevenson CA; Wang J; Wongthida P; Ter-Ovanesyan E; Ditty E; Bradley SP; Xu L; Yin M; Yurkovetskiy AV; Mosher R; Damelin M; Lowinger TB
Mol Cancer Ther; 2023 Sep; 22(9):999-1012. PubMed ID: 37294948
[TBL] [Abstract] [Full Text] [Related]
4. Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trial.
Senkus E; Delaloge S; Domchek SM; Conte P; Im SA; Xu B; Armstrong A; Masuda N; Fielding A; Robson M; Tung N
Int J Cancer; 2023 Aug; 153(4):803-814. PubMed ID: 36971103
[TBL] [Abstract] [Full Text] [Related]
5. The stromal tumor-infiltrating lymphocytes, cancer stemness, epithelial-mesenchymal transition, and B7-H4 expression in ovarian serous carcinoma.
Hwang C; Lee HJ; Na JY; Kim KH; Song YJ; Kim JY; Kim K; Shin DH; Park JY; Kim SY; Lee JH; Choi KU
J Ovarian Res; 2023 Jan; 16(1):3. PubMed ID: 36609273
[TBL] [Abstract] [Full Text] [Related]
6. The disruption of the ccdc6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma.
Morra F; Merolla F; Damia G; Ricci F; Varricchio S; Ilardi G; Arenare L; Califano D; Napolitano V; Fruscio R; Melillo RM; Palazzo L; Celetti A
J Exp Clin Cancer Res; 2022 Aug; 41(1):245. PubMed ID: 35964058
[TBL] [Abstract] [Full Text] [Related]
7. Histone deacetylase inhibitor, panobinostat, exerts anti-proliferative effect with partial normalization from aberrant epigenetic states on granulosa cell tumor cell lines.
Hazama Y; Tsujioka T; Kitanaka A; Tohyama K; Shimoya K
PLoS One; 2022; 17(7):e0271245. PubMed ID: 35802681
[TBL] [Abstract] [Full Text] [Related]
8. Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer.
Kraus FBT; Topalov NE; Deuster E; Hysenaj I; Mayr D; Chelariu-Raicu A; Beyer S; Kolben T; Burges A; Mahner S; Trillsch F; Jeschke U; Czogalla B
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2501-2511. PubMed ID: 35751684
[TBL] [Abstract] [Full Text] [Related]
9. Black coffee mitigates diethyl phthalate disrupted folliculogenesis, reduced gonadotropins, and ovarian lesions in female albino mice.
Ara C; Asmatullah ; Ramzan N; Ali S; Shakir HA; Liaqat I; Iqbal A; Yaseen F; Shahzad N
Environ Sci Pollut Res Int; 2022 Jul; 29(31):47254-47266. PubMed ID: 35182336
[TBL] [Abstract] [Full Text] [Related]
10. Arf6-mediated macropinocytosis-enhanced suicide gene therapy of C16TAB-condensed Tat/pDNA nanoparticles in ovarian cancer.
Sun Z; Huang J; Su L; Li J; Qi F; Su H; Chen Y; Zhang Q; Zhang Q; Li Z; Zhang S
Nanoscale; 2021 Sep; 13(34):14538-14551. PubMed ID: 34473182
[TBL] [Abstract] [Full Text] [Related]
11. SIRT1 and gynecological malignancies (Review).
Chen J; Chen H; Pan L
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649834
[TBL] [Abstract] [Full Text] [Related]
12. Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer.
Zhang GQ; Jiao Q; Shen CT; Song HJ; Zhang HZ; Qiu ZL; Luo QY
Cancer Sci; 2021 Mar; 112(3):997-1010. PubMed ID: 33247999
[TBL] [Abstract] [Full Text] [Related]
13. Antioxidant, Anti-Inflammatory and Cytotoxic Properties of
Hadjira S; Mansour A; Berkel C; Seghiri R; Menad A; Benayache F; Benayache S; Cacan E; Ameddah S
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(1):89-100. PubMed ID: 32516104
[TBL] [Abstract] [Full Text] [Related]
14. Identification of Novel Biomarkers of Homologous Recombination Defect in DNA Repair to Predict Sensitivity of Prostate cancer Cells to PARP-Inhibitors.
Criscuolo D; Morra F; Giannella R; Cerrato A; Celetti A
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242618
[TBL] [Abstract] [Full Text] [Related]
15. Haemanthamine alters sodium butyrate-induced histone acetylation, p21
Seifrtová M; Havelek R; Cahlíková L; Hulcová D; Mazánková N; Řezáčová M
Phytomedicine; 2017 Nov; 35():1-10. PubMed ID: 28991639
[TBL] [Abstract] [Full Text] [Related]
16. Targeted Proteomic Analyses of Histone H4 Acetylation Changes Associated with Homologous-Recombination-Deficient High-Grade Serous ovarian Carcinomas.
Thomas SN; Chen L; Liu Y; Höti N; Zhang H
J Proteome Res; 2017 Oct; 16(10):3704-3710. PubMed ID: 28866885
[TBL] [Abstract] [Full Text] [Related]
17. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.
Roskoski R
Pharmacol Res; 2017 Jul; 121():202-212. PubMed ID: 28465216
[TBL] [Abstract] [Full Text] [Related]
18. Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy.
Smith JB; Lanitis E; Dangaj D; Buza E; Poussin M; Stashwick C; Scholler N; Powell DJ
Mol Ther; 2016 Nov; 24(11):1987-1999. PubMed ID: 27439899
[TBL] [Abstract] [Full Text] [Related]
19. The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells.
Chen S; Zhao Y; Gou WF; Zhao S; Takano Y; Zheng HC
PLoS One; 2013; 8(11):e79781. PubMed ID: 24236158
[TBL] [Abstract] [Full Text] [Related]
20. Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3.
Meng F; Sun G; Zhong M; Yu Y; Brewer MA
Int J Oncol; 2013 Aug; 43(2):495-502. PubMed ID: 23709006
[TBL] [Abstract] [Full Text] [Related]
[Next]
